Barbara P.

Barbara P. is an experienced professional in the biotech and pharmaceuticals sectors, currently working in Operations at Dyve Biosciences since January 2014. Dyve focuses on advancing innovative treatments through a transdermal delivery platform and is conducting a Phase 2 clinical study for its lead asset, DYV700, aimed at treating acute gout. Prior to Dyve, Barbara held several significant roles, including Aesthetics Program Manager - Physician Advocate and Head of Operations at Viridian Pharmaceuticals LLC from October 2018 to December 2020, and Managing Director at Insource Medical from September 2012 to September 2017.